Login to Your Account



Financings Roundup

Regentis Raises $10M for Knee Cartilage Regeneration Product

By Catherine Shaffer
Staff Writer

Tuesday, May 15, 2012
A Series C financing round of $10 million will support clinical studies and commercial launch of Regentis Biomaterials Ltd.'s knee cartilage regeneration product, GelrinC, in Europe, including a sales force and a postmarket study.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription